Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-03-02 Sale |
2023-03-06 6:54 pm |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks |
1,610 | $15.83 | $25,481 | 66,090 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:52 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
1,434 | $15.83 | $22,696 | 94,901 (Direct) |
View |
| 2023-03-02 Sale |
2023-03-06 6:51 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,751 | $15.83 | $27,713 | 116,613 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:07 pm |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
2,368 | $15.96 | $37,796 | 45,693 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
7,815 | $15.93 | $124,483 | 587,106 (Indirect Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:05 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
1,850 | $15.9 | $29,421 | 38,406 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:04 pm |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
2,368 | $15.96 | $37,796 | 43,260 (Direct) |
View |
| 2023-02-28 Sale |
2023-03-02 7:03 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
2,005 | $15.96 | $32,002 | 254,644 (Direct) |
View |
| 2023-02-15 Sale |
2023-02-21 07:20 am |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $16.98 | $144,352 | 214,274 (Indirect Direct) |
View |
| 2023-02-13 Sale |
2023-02-15 7:09 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $17.01 | $17,012 | 594,921 (Indirect Direct) |
View |
| 2023-02-01 Sale |
2023-02-03 4:26 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $17 | $17,003 | 595,921 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:18 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $13.72 | $116,655 | 222,774 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-04 5:15 pm |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
1,475 | $15.01 | $22,136 | 41,564 (Direct) |
View |
| 2022-12-07 Sale |
2022-12-09 4:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $17.06 | $17,060 | 596,921 (Indirect Direct) |
View |
| 2022-11-21 Sale |
2022-11-22 7:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
1,720 | $18.19 | $31,289 | 19,535 (Direct) |
View |
| 2022-11-15 Sale |
2022-11-17 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
3,403 | $20.01 | $68,103 | 231,274 (Indirect Direct) |
View |
| 2022-11-07 Sale |
2022-11-09 4:39 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin See Remarks |
1,000 | $18 | $18,004 | 597,921 (Indirect Direct) |
View |
| 2022-10-07 Sale |
2022-10-11 6:47 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $19.51 | $19,510 | 598,921 (Indirect Direct) |
View |
| 2022-10-04 Sale |
2022-10-06 4:26 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,000 | $20.29 | $121,766 | 193,199 (Indirect Direct) |
View |
| 2022-09-07 Sale |
2022-09-09 5:10 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.51 | $21,510 | 599,921 (Indirect Direct) |
View |
| 2022-08-15 Sale |
2022-08-17 5:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,000 | $24.8 | $148,789 | 199,199 (Indirect Direct) |
View |
| 2022-08-05 Sale |
2022-08-09 5:16 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $24.74 | $61,858 | 979,233 (Indirect Direct) |
View |
| 2022-08-05 Purchase |
2022-08-09 4:34 pm |
Arcutis Biotherapeutics Inc. | ARQT | Frazier Life Sciences VIII L.P. FHM LIFE SCIENCES VIII L.P. FHM LIFE SCIENCES VIII L.L.C. Topper James N Heron Patrick J 10% Owner |
250,000 | $20 | $5,000,000 | 8,738,574 (Indirect Direct) |
View |
| 2022-07-18 Sale |
2022-07-18 6:53 pm |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
6,000 | $24.4 | $146,374 | 205,199 (Indirect Direct) |
View |
| 2022-07-08 Sale |
2022-07-12 7:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
2,197 | $25.41 | $55,835 | 256,649 (Direct) |
View |
| 2022-07-08 Sale |
2022-07-12 7:30 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
13,500 | $25.37 | $342,473 | 981,733 (Indirect Direct) |
View |
| 2022-07-06 Sale |
2022-07-07 4:04 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $22.07 | $22,070 | 876,298 (Indirect Direct) |
View |
| 2022-06-24 Sale |
2022-06-28 4:29 pm |
Arcutis Biotherapeutics Inc. | ARQT | ORBIMED ADVISORS LLC ORBIMED CAPITAL LLC OrbiMed Capital GP VII LLC 10% Owner |
341,971 | $21.31 | $7,287,402 | 415,142 (Indirect) |
View |
| 2022-06-06 Sale |
2022-06-06 4:06 pm |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
1,000 | $21.06 | $21,064 | 877,298 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-03-02 Option Award |
2023-03-06 6:57 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Lock Kenneth A. Chief Commercial Officer |
76,800 | $0 | 120,060 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:56 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | OSBORNE DAVID W Chief Technical Officer |
54,400 | $0 | 309,044 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:55 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
65,600 | $0 | 111,293 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:54 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Moore Matthew Richard See Remarks |
54,400 | $0 | 66,090 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:52 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remarks |
76,800 | $0 | 94,901 (Direct) |
View |
| 2023-03-02 Option Award |
2023-03-06 6:51 pm |
N/A 2033-03-02 |
Arcutis Biotherapeutics Inc. | ARQT | Burnett Patrick See Remarks |
76,800 | $0 | 116,613 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-21 07:20 am |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $1.6806 | 214,274 (Direct) |
View |
| 2023-02-15 Exercise |
2023-02-21 07:20 am |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $0 | 214,274 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-18 8:18 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $1.68 | 222,774 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-18 8:18 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
8,500 | $0 | 222,774 (Direct) |
View |
| 2022-11-18 Option Award |
2022-11-22 7:06 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Matsuda Masaru See Remark |
4,875 | $0 | 19,535 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 4:29 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,020 | $1.68 | 231,274 (Direct) |
View |
| 2022-11-15 Exercise |
2022-11-17 4:29 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
1,020 | $0 | 231,274 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-20 4:37 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
5,000 | $1.6806 | 77,533 (Direct) |
View |
| 2022-09-16 Exercise |
2022-09-20 4:37 pm |
N/A 2029-06-11 |
Arcutis Biotherapeutics Inc. | ARQT | Burrows Scott L Chief Financial Officer |
5,000 | $0 | 77,533 (Direct) |
View |
| 2022-06-23 Gift |
2022-09-09 5:10 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
268,964 | $0 | 599,921 (Direct) |
View |
| 2022-09-02 Option Award |
2022-09-06 7:08 pm |
N/A 2032-09-02 |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
29,482 | $0 | 29,482 (Direct) |
View |
Ownership |
2022-09-06 5:45 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Krishnamohan Neha Director |
0 | $0 | 1,232 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 5:16 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $1.6806 | 979,233 (Direct) |
View |
| 2022-08-05 Exercise |
2022-08-09 5:16 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
2,500 | $0 | 979,233 (Direct) |
View |
| 2022-03-23 Exercise(A) |
2022-08-04 8:42 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
15,331 | $6.52 | 191,056 (Direct) |
View |
| 2022-03-23 Exercise(A) |
2022-08-04 8:42 pm |
N/A 2029-11-20 |
Arcutis Biotherapeutics Inc. | ARQT | Turney Patricia A. SVP, Operations |
15,331 | $0 | 191,056 (Direct) |
View |
| 2022-07-08 Exercise |
2022-07-12 7:30 pm |
N/A N/A |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
7,087 | $1.6806 | 981,733 (Direct) |
View |
| 2022-07-08 Exercise |
2022-07-12 7:30 pm |
N/A 2029-03-13 |
Arcutis Biotherapeutics Inc. | ARQT | Watanabe Todd Franklin President and CEO |
7,087 | $0 | 981,733 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:58 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Curran Terrie Director |
16,108 | $0 | 16,108 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:57 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | CHAUDHURI BHASKAR Director |
16,108 | $0 | 907,480 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:56 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Gilbert Halley E Director |
16,108 | $0 | 16,108 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 4:55 pm |
N/A 2032-06-01 |
Arcutis Biotherapeutics Inc. | ARQT | Welgus Howard G. Director |
16,108 | $0 | 222,995 (Direct) |
View |